Biotech SF
San Francisco Bay Area biotech stories.
Tuesday, January 4, 2011
Xoma snags up to $505M, including $35M upfront, for anti-inflammation/diabetes drug
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment